These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3106125)

  • 1. Prolongation of rat pancreatic islet allograft survival by treatment of recipient rats with monoclonal anti-interleukin-2 receptor antibody and cyclosporin.
    Hahn HJ; Kuttler B; Dunger A; Klöting I; Lucke S; Volk HD; von Baehr R; Diamantstein T
    Diabetologia; 1987 Jan; 30(1):44-6. PubMed ID: 3106125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-Ia antibodies, culture, and cyclosporin on prolongation of canine islet allograft survival.
    Alejandro R; Latif Z; Noel J; Shienvold FL; Mintz DH
    Diabetes; 1987 Mar; 36(3):269-73. PubMed ID: 3100370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of rat islet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1.
    Yang H; Issekutz TB; Wright JR
    Transplantation; 1995 Jul; 60(1):71-6. PubMed ID: 7624946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of donor specific unresponsiveness in rat islet allografts: importance of transplant site for induction by cyclosporin A and maintenance.
    Kamei T; Yasunami Y
    Diabetologia; 1989 Nov; 32(11):779-85. PubMed ID: 2512192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cyclosporin-A, low-temperature culture, and anti-Ia antibodies on prevention of rejection of rat islet allografts.
    Terasaka R; Lacy PE; Hauptfeld V; Bucy RP; Davie JM
    Diabetes; 1986 Jan; 35(1):83-8. PubMed ID: 3079714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated pancreatic islet allografts in rats rendered immunologically unresponsive to renal allografts. The effect of the site of transplantation.
    Gray DW; Reece-Smith H; Fairbrother B; McShane P; Morris PJ
    Transplantation; 1984 May; 37(5):434-7. PubMed ID: 6233763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
    Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
    J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
    Kuttler B; Kauert C; Wanka H; Diamantstein T; Hahn HJ
    J Autoimmun; 1996 Jun; 9(3):321-9. PubMed ID: 8816967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K; Tilney NL; Stunkel KG; Hancock WW; Diamantstein T; Kupiec-Weglinski JW
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of allograft survival in diabetic rats treated with cyclosporine by deoxyguanosine pretreatment of pancreatic islets of Langerhans.
    al-Abdullah IH; Kumar AM; al-Adnani MS; Abouna GM
    Transplantation; 1991 May; 51(5):967-71. PubMed ID: 2031280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of direct ultraviolet irradiation and cyclosporine in facilitating indefinite pancreatic islet allograft acceptance.
    Lau H; Reemtsma K; Hardy MA
    Transplantation; 1984 Dec; 38(6):566-9. PubMed ID: 6438844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic islet transplantation. Induction of graft acceptance by ultraviolet irradiation of donor tissue.
    Hardy MA; Lau H; Weber C; Reemtsma K
    Ann Surg; 1984 Oct; 200(4):441-50. PubMed ID: 6237621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with Anti-FcεRIα (MAR-1) Antibody Prevents Acute Islet Allograft Rejection in a Murine Model.
    Yazawa N; Imaizumi T; Makuuchi H; Tsuchiya I; Tanaka M; Inokuchi S; Habu S; Nakagohri T
    Tokai J Exp Clin Med; 2015 Dec; 40(4):141-8. PubMed ID: 26662664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD8 abrogates effect of anti-CD4-mediated islet allograft survival in rat model.
    Seydel K; Shizuru J; Grossman D; Wu A; Alters S; Fathman CG
    Diabetes; 1991 Nov; 40(11):1430-4. PubMed ID: 1834499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet transplantation--synergism between antilymphocyte and antimacrophage agents.
    Nash JR; Bell PR
    J Surg Res; 1984 Feb; 36(2):154-7. PubMed ID: 6319820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection.
    Kirkman RL; Barrett LV; Gaulton GN; Kelley VE; Koltun WA; Schoen FJ; Ythier A; Strom TB
    Transplantation; 1985 Dec; 40(6):719-22. PubMed ID: 3934807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment.
    Ohtsuka K; Yasunami Y; Ikehara Y; Nagai T; Kodama S; Maki T; Tomita A; Abo T; Ikeda S
    Transplantation; 1997 Aug; 64(4):633-9. PubMed ID: 9293878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.